Inhibition of epidermal growth factor receptor signaling elevates 15-hydroxyprostaglandin dehydrogenase in non-small-cell lung cancer.
about
GSK3β controls epithelial-mesenchymal transition and tumor metastasis by CHIP-mediated degradation of SlugExpression of 15-PGDH is downregulated by COX-2 in gastric cancer.Cellular uptake and antiproliferative effects of 11-oxo-eicosatetraenoic acid.Targeting the eicosanoid pathway in non-small-cell lung cancer.A PTP4A3 peptide PIMAP39 modulates TNF-alpha levels and endotoxic shock.MUC1 regulates expression of multiple microRNAs involved in pancreatic tumor progression, including the miR-200c/141 cluster.15-PGDH is reduced and induces apoptosis and cell cycle arrest in gastric carcinoma.The skinny on Slug.15-hydroxyprostaglandin dehydrogenase-derived 15-keto-prostaglandin E2 inhibits cholangiocarcinoma cell growth through interaction with peroxisome proliferator-activated receptor-γ, SMAD2/3, and TAP63 proteins.Decreased expression of 15-hydroxyprostaglandin dehydrogenase in gastric carcinomasBile acids inhibit NAD+-dependent 15-hydroxyprostaglandin dehydrogenase transcription in colonocytes.15-PGDH inhibits hepatocellular carcinoma growth through 15-keto-PGE2/PPARγ-mediated activation of p21WAF1/Cip1.Role of 15-hydroxyprostaglandin dehydrogenase down-regulation on the prognosis of hepatocellular carcinoma.The EMT regulator slug and lung carcinogenesis.Prostaglandin catabolic enzymes as tumor suppressors.15-Hydroxyprostaglandin dehydrogenase is a target of hepatocyte nuclear factor 3beta and a tumor suppressor in lung cancer.Tumor-derived TGF-β and prostaglandin E2 attenuate anti-tumor immune responses in head and neck squamous cell carcinoma treated with EGFR inhibitorEpidermal growth factor down-regulates the expression of neutrophil gelatinase-associated lipocalin (NGAL) through E-cadherin in pancreatic cancer cells.15-hydroxyprostaglandin dehydrogenase is downregulated and exhibits tumor suppressor activity in gastric cancer.The Epstein-Barr virus latent membrane protein 1 and transforming growth factor--β1 synergistically induce epithelial--mesenchymal transition in lung epithelial cells.Loss of 15-hydroxyprostaglandin dehydrogenase increases prostaglandin E2 in pancreatic tumors.HGF/Met signalling promotes PGE(2) biogenesis via regulation of COX-2 and 15-PGDH expression in colorectal cancer cells.Colorectal neoplasia goes with the flow: prostaglandin transport and termination.Rebamipide, a mucoprotective drug, inhibits NSAIDs-induced gastric mucosal injury: possible involvement of the downregulation of 15-hydroxyprostaglandin dehydrogenase.UV radiation inhibits 15-hydroxyprostaglandin dehydrogenase levels in human skin: evidence of transcriptional suppression.NAD+-dependent 15-hydroxyprostaglandin dehydrogenase regulates levels of bioactive lipids in non-small cell lung cancer.Cyclooxygenase 2 in liver dysfunction and carcinogenesis: Facts and perspectives.Cypripedin diminishes an epithelial-to-mesenchymal transition in non-small cell lung cancer cells through suppression of Akt/GSK-3β signalling.
P2860
Q30583575-48EC3A02-505B-45BB-BFC0-64D38763D629Q33313240-3E7D775F-3F71-4849-A593-BED3D1193F22Q33458922-B636ECB4-44D6-4998-AEBD-2224B50D029EQ33936807-E1F73F0C-6819-4073-B0AF-7CCAA933F75AQ34145819-24C938C4-A99C-4A02-8447-30913F2F7B14Q35021578-0B02621F-59C2-47CA-9FEC-6F0AA104646CQ35813184-AA4DC79C-DE4F-416C-B9A9-12DFEDBDB4D0Q36784315-388865BC-517B-4BC6-9900-4C990EFCFC8FQ37000533-E75F172A-6A9A-4F60-8F88-31E5CA9DC1F0Q37065177-E3E1A229-E68D-4F75-8DC6-E422D1F7E268Q37337699-1FB790C4-E472-44C7-9EFB-AD6A750DBBDEQ37549404-4D67499C-93CB-4F5F-B12B-90A97762B701Q37711314-4297831D-FBCC-40FC-AFBA-C8F84939B1F7Q37888326-E804C757-8468-406A-A8B1-F504888B7100Q37948688-AE9FEF9E-0E1C-4BCA-8B7F-91A9EFE4FFF9Q38289660-CF859F74-EC69-48FE-9C26-DEB76F644289Q38954685-6DE41340-EF30-4B79-9494-0A4C39971A0EQ39533928-6FD9B296-E19E-4EFB-A716-595097AF83DEQ39563381-30B28557-2B3D-4962-810D-38C91D90150FQ39669856-655BDECD-4B74-4DB2-B1C4-5398810B748AQ39788786-4A6545E1-4E18-4857-9BAA-8A7D82463F72Q39819780-0B3E5BEE-C3A6-45F0-8223-88C332A0BFEAQ42071849-8D952AD8-315B-4D47-A8FB-B3CC80524ACCQ42087629-E671235A-A527-4103-A85B-CDDB8CCFD9EBQ42114996-37DF8D43-EFD1-44D4-A8D4-B35A6F7AAEACQ42123794-A84E1FD8-5612-42A9-A8A8-23732E7265DCQ42345064-83E096C1-605F-46E9-A3E1-D2E1E87B2435Q54978473-6007C09D-DD43-470E-82F3-A367CBDDA509
P2860
Inhibition of epidermal growth factor receptor signaling elevates 15-hydroxyprostaglandin dehydrogenase in non-small-cell lung cancer.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Inhibition of epidermal growth ...... in non-small-cell lung cancer.
@en
type
label
Inhibition of epidermal growth ...... in non-small-cell lung cancer.
@en
prefLabel
Inhibition of epidermal growth ...... in non-small-cell lung cancer.
@en
P2093
P1433
P1476
Inhibition of epidermal growth ...... in non-small-cell lung cancer.
@en
P2093
Adriana Gonzalez
Carlos L Arteaga
David H Johnson
David P Carbone
Dean Billheimer
Hsin-Hsiung Tai
Joseph M Amann
Kyung-Ho Park
Marta Guix
P304
P356
10.1158/0008-5472.CAN-06-2287
P407
P577
2007-06-01T00:00:00Z